Literature DB >> 19005758

Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

Do Young Kim1, Seung Up Kim, Sang Hoon Ahn, Jun Yong Park, Jung Min Lee, Young Nyun Park, Ki Tae Yoon, Yong Han Paik, Kwan Sik Lee, Chae Yoon Chon, Kwang-Hyub Han.   

Abstract

BACKGROUND: It is difficult to differentiate early compensated cirrhosis from chronic hepatitis solely by clinical features. The aim of this study was to assess the usefulness of liver stiffness measurement (LSM) for detection of early compensated liver cirrhosis in chronic hepatitis B (CHB).
METHODS: Ninety-one consecutive CHB patients who underwent liver biopsy (LB) and LSM were recruited. All patients did not fulfill the clinical criteria for cirrhosis. The cutoff of LSM for cirrhosis was 10.3 kPa.
RESULTS: All patients were divided into either group A (cirrhosis) or group B (CHB) according to LB result. The median LSM values of groups A and B were 11.8 and 7.6 kPa, respectively (P < 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of LSM in predicting cirrhosis were 0.59, 0.78, 0.68, and 0.72, respectively. The area under the receiver operating characteristics curve (AUROC) of LSM was 0.803, whereas the AUROCs of aspartate to alanine aminotransferase ratio (AAR) and aspartate aminotransferase to platelet ratio index (APRI) were 0.488 and 0.723, respectively.
CONCLUSIONS: LSM showed an acceptable diagnostic accuracy for detecting early compensated cirrhosis in CHB.

Entities:  

Mesh:

Year:  2008        PMID: 19005758     DOI: 10.1007/s10620-008-0541-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 3.  Treatment options in HBV.

Authors:  Antonio Craxì; Giorgio Antonucci; Calogero Cammà
Journal:  J Hepatol       Date:  2005-11-28       Impact factor: 25.083

4.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Authors:  G Fattovich; G Giustina; F Degos; F Tremolada; G Diodati; P Almasio; F Nevens; A Solinas; D Mura; J T Brouwer; H Thomas; C Njapoum; C Casarin; P Bonetti; P Fuschi; J Basho; A Tocco; A Bhalla; R Galassini; F Noventa; S W Schalm; G Realdi
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

5.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

6.  Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Authors:  Carolin Lackner; Gerd Struber; Bernadette Liegl; Sebastian Leibl; Petra Ofner; Csilla Bankuti; Bernd Bauer; Rudolf E Stauber
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

Authors:  F Degos; C Christidis; N Ganne-Carrie; J P Farmachidi; C Degott; C Guettier; J C Trinchet; M Beaugrand; S Chevret
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

8.  Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.

Authors:  L Benvegnù; M Gios; S Boccato; A Alberti
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

10.  Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.

Authors:  Beom Kyung Kim; Sung Ae Kim; Young Nyun Park; Jae Youn Cheong; Hwa Sook Kim; Jun Yong Park; Sung Won Cho; Kwang-Hyub Han; Chae Yoon Chon; Young Myoung Moon; Sang Hoon Ahn
Journal:  Liver Int       Date:  2007-09       Impact factor: 5.828

View more
  50 in total

Review 1.  Four-dimensional flow magnetic resonance imaging in cirrhosis.

Authors:  Zoran Stankovic
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.

Authors:  Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Eun Hee Choi; Jae Yeon Seok; Jung Min Lee; Young Nyun Park; Chae Yoon Chon; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

Review 3.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

4.  Transient elastography in chronic hepatitis B: an Asian perspective.

Authors:  Seung Up Kim; Kwang-Hyub Han; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 5.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  The Evolving Role of Advanced Endoscopic Techniques in Hepatology.

Authors:  Mahmoud Mahfouz; Sunil Amin; Andres F Carrion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-02

7.  Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.

Authors:  Vincent Wai-Sun Wong; Pietro Lampertico; Victor de Lédinghen; Pik Eu Chang; Seung Up Kim; Yongpeng Chen; Henry Lik-Yuen Chan; Giampaolo Mangia; Juliette Foucher; Wan Cheng Chow; Sang Hoon Ahn; Jinlin Hou
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

Review 8.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

9.  Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B.

Authors:  James Fung; Ching-Lung Lai; David But; Axel Hsu; Wai-Kay Seto; Charles Cheng; Danny Ka-Ho Wong; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2010-07-24       Impact factor: 6.047

10.  Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.

Authors:  Sang Hoon Ahn; Henry L Y Chan; Pei-Jer Chen; Jun Cheng; Mahesh K Goenka; Jinlin Hou; Seng Gee Lim; Masao Omata; Teerha Piratvisuth; Qing Xie; Hyung Joon Yim; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2010-02-20       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.